Cognitive Behavioural Analysis System of Psychotherapy (CBASP) for chronic depression: Clinical characteristics and six month clinical outcomes in an open case series.

被引:16
|
作者
Swan, John S. [1 ]
MacVicar, Robert [2 ,3 ]
Christmas, David [2 ,3 ]
Durham, Rob [2 ,3 ]
Rauchhaus, Petra [4 ]
McCullough, James P., Jr. [5 ]
Matthews, Keith [1 ]
机构
[1] Univ Dundee, Ninewells Hosp & Med Sch, Med Res Inst, Div Neurosci, Dundee DD1 9SY, Scotland
[2] NHS Tayside, Adv Intervent Serv, Dundee DD1 9SY, Scotland
[3] Univ Dundee, Ninewells Hosp & Med Sch, Dundee DD1 9SY, Scotland
[4] Univ Dundee, Med Res Inst, Dundee Epidemiol & Biostat Unit, Div Populat Hlth Sci, Dundee DD1 9SY, Scotland
[5] Virginia Commonwealth Univ, Dept Psychol, Richmond, VA 23284 USA
关键词
Case series; Chronic depression; CBASP; Psychotherapy; Treatment refractory; CHRONIC MAJOR DEPRESSION; CHRONIC FORMS; DSM-IV; DISORDERS; ONSET; CLASSIFICATION; COMBINATION; DYSTHYMIA; VALIDITY; BURDEN;
D O I
10.1016/j.jad.2013.09.024
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Evidence-based guidance on how best to treat chronic depression is limited. Cognitive Behavioural Analysis System of Psychotherapy (CBASP) has shown some promise with this 'difficult-to-treat' clinical group. This case series was designed to assess the acceptability and utility of this novel treatment in routine clinical practice within the U.K. National Health Service. Methods: We offered an open trial of CBASP to a cohort of 115 referred patients within primary and secondary care. Diagnostic interview and standardised outcome measures were administered before and after 6 months of CBASP with a trained, accredited therapist. Results: Seventy-four patients entered therapy, with 46 completing. 30% met criteria for remission (<= 8 HRSD-24 score) and a further 30% met criteria for clinically significant change (> 8 and <= 15 HRSD-24 plus 50% reduction in baseline score). Thirty-nine per cent made "No change". Group measures of quality of life, social functioning and interpersonal functioning also improved. Limitations: This was an open study design with a moderate sample size and no control group. Ratings were not completed using a blinded procedure. Conclusions: CBASP is an acceptable therapy for a large proportion of patients with chronic depression and was associated with clinically significant change in 60% of completers. Crown Copyright (C) 2013 Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:268 / 276
页数:9
相关论文
共 38 条
  • [31] Perceived Physical Health and Cognitive Behavioral Therapy vs Supportive Psychotherapy Outcomes in Adults With Late-Life Depression A Secondary Analysis of a Randomized Clinical Trial
    Dafsari, Forugh S.
    Bewernick, Bettina
    Boehringer, Sabine
    Domschke, Katharina
    Elsaesser, Moritz
    Loebner, Margrit
    Luppa, Melanie
    Schmitt, Sandra
    Wingenfeld, Katja
    Wolf, Elena
    Zehender, Nadine
    Hellmich, Martin
    Mueller, Wiebke
    Wagner, Michael
    Peters, Oliver
    Froelich, Lutz
    Riedel-Heller, Steffi
    Schramm, Elisabeth
    Hautzinger, Martin
    Jessen, Frank
    JAMA NETWORK OPEN, 2024, 7 (04) : E245841
  • [32] Clinical Variants, Characteristics, and Outcomes Among COVID-19 Patients: A Case Series Analysis at a Tertiary Care Hospital in Karachi, Pakistan
    Ahsan, Tasnim
    Rani, Bharta
    Siddiqui, Roomana
    D'Souza, Glenis
    Memon, Razzaq
    Lutfi, Irfan
    Hasan, Omer, I
    Javed, Rushma
    Khan, Farhan
    Hassan, Muhammad
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (04)
  • [33] A Prospective, Single-center, Open-label Case Series Evaluating the Clinical Outcomes of Lyopreserved Placental Membrane Containing Viable Cells in the Treatment of Chronic Wounds
    Reyzelman, Alexander M.
    Vartivarian, Mher
    Danilkovitch, Alla
    Saunders, Molly C.
    WOUNDS-A COMPENDIUM OF CLINICAL RESEARCH AND PRACTICE, 2019, 31 (04): : 97 - 102
  • [34] Early and eighteen month clinical outcomes of first UK case of percutaneous deep vein arterialisation (pDVA) to treat “no option” chronic limb-threatening ischemia using the LimFlow system
    Symeon Lechareas
    Kaji Sritharan
    R. G. Mc Williams
    CVIR Endovascular, 4
  • [35] Early and eighteen month clinical outcomes of first UK case of percutaneous deep vein arterialisation (pDVA) to treat "no option" chronic limb-threatening ischemia using the LimFlow system
    Lechareas, Symeon
    Sritharan, Kaji
    Mc Williams, R. G.
    CVIR ENDOVASCULAR, 2021, 4 (01)
  • [36] Inversed probability case-control analysis of operative burr hole evacuation versus subdural evacuating port system for chronic subdural hematomas: Clinical and economic outcomes?
    Mohan, Arvind
    Malnik, Samuel
    Grady, Clare
    Lucke-Wold, Brandon
    Kubilis, Paul
    Hoh, Brian L.
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2022, 220
  • [37] Clinical Effectiveness and Impact on Patient-Reported Outcomes of Delayed-Release Dimethyl Fumarate in Relapsing Multiple Sclerosis Patients after Suboptimal Response to Glatiramer Acetate: Six-Month Interim Analysis of a Prospective, Multicenter, Open-Label, Single-Arm, Observational Study (RESPOND)
    Kresa-Reahl, Kiren
    Repovic, Pavle
    Robertson, Derrick
    Okwuokenye, Macaulay
    Meltzer, Leslie
    Mann, Monica
    NEUROLOGY, 2016, 86
  • [38] Clinical Effectiveness and Impact on Patient-Reported Outcomes of Delayed-Release Dimethyl Fumarate in Relapsing Multiple Sclerosis Patients after Suboptimal Response to Glatiramer Acetate: Six-Month Interim Analysis of a Prospective, Multicenter, Open-Label, Single-Arm, Observational Study (RESPOND)
    Kresa-Reahl, Kiren
    Repovic, Pavle
    Robertson, Derrick
    Okwuokenye, Macaulay
    Meltzer, Leslie
    Mann, Monica
    NEUROLOGY, 2016, 86